SpaceX IPO Opens to Retail Investors Through Robinhood, Fidelity, and Schwab
Mondeum Capital (UK) Limited

SpaceX has announced that some shares will be available through Robinhood, Fidelity, and Charles Schwab. This means everyday traders can access the IPO at the same price and time as big institutional buyers. Here’s what this means for retail investors and why it’s important to pay attention to the details.
This approach is different from the usual IPO process, where big institutional clients get first pick and retail investors often have to wait until trading starts, usually paying higher prices. By letting people buy shares directly through major retail brokerages, SpaceX is changing how major IPOs are handled.
SpaceX announced this week that it will list on Nasdaq with the ticker SPCX, after filing confidentially with regulators in April. The company will start presenting its plans to investors on June 8.
SpaceX started in 2002 as a small rocket company and has become one of the world’s most valuable private businesses. It is now NASA’s main launch partner since the space shuttle program ended. SpaceX also works on reusable rockets, national security and defense projects, and runs Starlink, a satellite internet network with about 10,000 satellites. Starlink now brings in a large part of the company’s revenue.
There are still some important things to keep in mind for retail investors. Each brokerage will have its own rules and requirements for buying shares. IPO shares are usually limited, and many people expect demand for SpaceX stock to be much higher than the supply. As a result, many retail investors who try to buy may get only a small number of shares or none at all.
Recent news

IMAX Stock Jumps 15% on Sale Reports: Who’s Buying?
IMAX is considering a sale, sparking speculation about buyers. Shares rose 15% Friday after the Wall Street Journal reported IMAX approached entertainment companies. The process is early and may not end in a deal. Here are the analysts’ top buyer picks and what each could gain with IMAX. Netflix is attracting the most attention as […]

Merck Shares Jump 4.9% on Cancer Trial Win as Keytruda Patent Cliff Looms
Merck wants to show it is not just a one-drug company, and Friday’s clinical trial results gave it a boost. Shares rose 4.9% in premarket trading after a partner drug worked well in advanced lung cancer when used with Merck’s main cancer treatment. At the same time, European regulators moved closer to approving another Keytruda […]

Micron Stock Slips 1% After a Volatile Week for Memory Chip Stocks
Micron shares slipped 1% in early Friday trading after a week of ups and downs. The stock climbed from below $660 to a 4.1% gain on Thursday, but then fell back by Friday morning. This week, the memory chip sector was influenced by remarks from a competitor’s CEO, a narrowly avoided strike at Samsung, and […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.
Featured Courses